Wael AlAnazi: Exceptional HLA-Matched Transplant Outcomes With Novel Thiotepa-Based Conditioning
Wael AlAnazi, Chairman and Hematology-Oncology Consultant at King Fahad Specialist Hospital Dammam, shared Syed Osman Ahmed‘s post on LinkedIn, adding:
“Impressive results!!!
I think this may be reference for sickle cell disease transplantation.
Do you have similar observations in Thalassemia?”
Syed Osman Ahmed, Consultant and Adult Hematologist at King Faisal Specialist Hospital and Research Centre, shared a post on LinkedIn about a recent article by Reem Alasbali et al. published in Bone Marrow Transplantation, adding:
“Outstanding outcomes in HLA-matched related donor transplant in adolescents and adults with sickle cell disease!
- 100% 2 year survival
- 0% Transplant related mortality
- 0% graft failure
- 0% Chronic Graft versus host disease
- Only 4% severe acute GVHD
Practice changing.
Congratulations to the authors of this collaborative work by Reem Alasbali et al led by Ali AlAhmari of King Faisal Specialist Hospital and Research Center and teams from Ministry of National Guard Health Affairs, Riyadh, Vanderbilt University Medical Center, Nashville and Imperial College London.”
Title: Excellent outcomes using a novel reduced intensity conditioning with thiotepa and post-transplant cyclophosphamide for HLA-matched related donor transplant in adolescents and adults with sickle cell disease
Authors: Reem Alasbali, Mohsen Alzahrani, Karina Wilkerson, Phavina Akhom, Fahad Alotaibi, Bader Alahmari, Josu de la Fuente, Michael R. DeBaun, Walid Rasheed, Hadeel Samarkandi, Riad El Fakih, Mostafa Saleh, Tusneem Elhassan, Hazza Alzahrani, Mahmoud Aljurf, Fahad Almohareb, Adetola A. Kassim, Ali AlAhmari
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 12, 2026, 07:58Brian O Mahony: Could NXT-007 Minimize the Need for Perioperative FVIII
-
Jul 12, 2026, 07:50Shayan Mohammadmoradi: Connecting the Next Generation of Hemostasis Researchers at ISTH 2026
-
Jul 12, 2026, 07:42Alexandra Yakusheva: ThrombInnov Debuts at ISTH 2026 with a Focus on Translational Research
-
Jul 12, 2026, 07:34Wolfgang Miesbach: ISTH 2026 Explores the Next Generation of APS Diagnostics
-
Jul 12, 2026, 07:28Sara Zalghout: ISTH 2026 Highlights Progress in Thromboinflammation Research
-
Jul 12, 2026, 07:13Ekaterina Balaian: Finding Healing Through Art at ISTH 2026
-
Jul 12, 2026, 06:59Maaike Sybil Jongen: Flow Cytometry for Platelet Phenotyping at ISTH 2026
-
Jul 12, 2026, 06:45Brian O Mahony: Advancing Concizumab Therapy for Hemophilia With Inhibitors at ISTH 2026
-
Jul 12, 2026, 06:42PERT-Guided Patient Selection for Advanced Pulmonary Embolism Therapies